Incidence of impaired glucose regulation (IGR) and progression to Type 2 diabetes in the Tayside region of Scotland

被引:0
|
作者
Eades, C. [1 ]
Leese, G. [2 ]
Evans, J. [1 ]
机构
[1] Univ Stirling, Sch Nursing Midwifery & Hlth, Stirling FK9 4LA, Scotland
[2] Univ Dundee, Sch Med, Dundee, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:116 / 116
页数:1
相关论文
共 50 条
  • [21] Risk of Progression to Type 2 Diabetes (T2D) and Regression to Normal Glucose Regulation (NGR) in People with Impaired Glucose Tolerance (IGT)
    Herman, William H.
    Barrett-Connor, Elizabeth L.
    Dabelea, Dana M.
    Edelstein, Sharon L.
    Horton, Edward S.
    Kahn, Steven E.
    Knowler, William C.
    Lorenzo, Carlos
    Mather, Kieren J.
    Perreault, Leigh
    Pan, Qing
    Pi-Sunyer, Xavier
    Venditti, Elizabeth M.
    Ye, Wen
    Zhang, Ping
    DIABETES, 2016, 65 : A370 - A371
  • [22] Predictors of progression to Type 2 diabetes or regression to normal glucose tolerance in persons with impaired glucose tolerance
    D'Agostino, RB
    Haffner, S
    Bergman, R
    Wagenknecht, L
    Rewers, M
    DIABETES, 2000, 49 : A386 - A387
  • [23] Nutritional regulation of incretin secretion in controls, impaired glucose tolerance and type 2 diabetes
    Nejad, F. Keyhani
    Kemper, M.
    Schueler, R.
    Pivovarova, O.
    Rudovich, N.
    Pfeiffer, A. F. H.
    DIABETOLOGIA, 2015, 58 : S340 - S340
  • [24] Risk factors for progression of type 2 diabetes from impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) in Japanese male
    Masukawa, H
    Miura, Y
    Oiso, Y
    Wakai, K
    Tsushita, K
    DIABETES, 2001, 50 : A202 - A202
  • [25] Evaluating the risk of developing postpartum impaired glucose regulation and Type 2 diabetes in women with gestational diabetes
    Balafshan, T.
    Purewal, T.
    Tang, A.
    Scroxton, A.
    Kalathil, D.
    DIABETIC MEDICINE, 2019, 36 : 23 - 23
  • [26] Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?
    Jaakko Tuomilehto
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 212 - 213
  • [27] Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?
    Tuomilehto, Jaakko
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (03): : 212 - 213
  • [28] Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals The Finnish Diabetes Prevention Study
    de Mello, Vanessa D. F.
    Lindstrom, Jaana
    Eriksson, Johan
    Ilanne-Parikka, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Sundvall, Jouko
    Laakso, Markku
    Tuomilehto, Jaakko
    Uusitupa, Matti
    DIABETES CARE, 2012, 35 (02) : 211 - 217
  • [29] Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus
    Wang, Chun
    Lv, Lifang
    Yang, Yanzhi
    Chen, Dawei
    Liu, Guanjian
    Chen, Lihong
    Song, Yuanxia
    He, Liping
    Li, Xiujun
    Tian, Haoming
    Jia, Weiping
    Ran, Xingwu
    CLINICAL ENDOCRINOLOGY, 2012, 76 (06) : 810 - 815
  • [30] Progression from gestational diabetes to type 2 diabetes in one region of Scotland: an observational follow-up study
    Claire E Eades
    Maggie Styles
    Graham P Leese
    Helen Cheyne
    Josie MM Evans
    BMC Pregnancy and Childbirth, 15